Corning Incorporated

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
Join Corning to learn about new vial parenteral packaging technology that increases drug product quality by addressing the root cause of issues associated with conventional glass containers. Allison Matusick, Corning Global Account Director and subject matter expert, will share how this new packaging is capable of reducing glass damage and breakage in extreme applications, reducing particulate generation, eliminating delamination, improving manufacturing efficiency for sterile injectable drugs and improving quality to enhance patient safety. Adoption of this next generation glass may positively impact regulations, improve bio manufacturing throughput, and could potentially alleviate quality control practices for bio manufacturing operations relevant to costly container crack failures.
Ticker:
GLW
Exchange:
27.02
Company Type:
Company Website:
Company HQ State:
New York
Company HQ Country:
United States
Year Founded:
Not Provided
Main Therapeutic Focus:
Lead Product in Development:
Valor Glass
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Global Accounts Director
Corning Incorporated